Latest News
ESMO 2025: CStone Discloses Phase I Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)
SUZHOU, China, Oct. 19, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key disease areas, today announced the first disclosure...
Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Once-Monthly Subcutaneous Depot Treatment Formulation of Small Molecule GLP-1R Agonist ASC30 for Obesity
- The 12-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of the once-monthly subcutaneous (SQ) depot formulation (treatment formulation) ofsmall molecule GLP-1 receptor (GLP-1R) agonist ASC30 in 65 participants with obesity or overweight. - The ult...
Leading Competition Economist Dr. Luke Wainscoat Joins The Brattle Group
SYDNEY, Oct. 20, 2025 /PRNewswire/ -- The Brattle Group has welcomed Dr. Luke
Wainscoat
Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances
SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd.
Webull Reduces Minimum ASX Trading Fee To $1
* Webull Australia now offers the lowest-cost CHESS-sponsored brokerage fee minimums for trading ASX shares * The new pricing structure is paired with Webull's industry-leading technology and free live pricing data * $1.00 minimum fees will be made available to Australian clients from 20 Oc...
Yaber Expands Its Global Footprint -- Now Available at JB Hi-Fi Across Australia
SYDNEY, Oct. 20, 2025 /PRNewswire/ -- Yaber, a pioneer of entertainment
projectors, now announces its official entry intoJB Hi-Fi
Razor Labs Expands Predictive Maintenance Coverage in Australia with Mobile Fleet AI Solution Launch at IMARC 2025
The company introduces its proven Mobile Fleet Predictive Maintenance solution
toAustralia, completing its full-suite offering for mining reliability.
SYDNEY, Oct. 20, 2025 /PRNewswire/ -- Razor Labs
Significant OS Benefit with Cadonilimab in First-Line Advanced Gastric Cancer: Final Analysis of COMPASSION-15 Presented at ESMO 2025
HONG KONG, Oct. 19, 2025 /PRNewswire/ -- On October 19, 2025, Akeso (9926.HK) announced the final analysis results from the COMPASSION-15/AK104-302 study at the 2025 European Society of Medical Oncology Congress (ESMO 2025) . COMPASSION-15 is a Phase III clinical trial evaluating cadonilimab, Ak...
HARMONi-6 Data: mPFS 11.14 Months (HR=0.6, P<0.0001) Simultaneously Released at ESMO and in The Lancet
* Ivonescimab plus chemotherapy demonstrated a median PFS of 11.14 months, PFS HR=0.60, P < 0.0001. * The absolute difference in median PFS between the two groups was 4.24 months (ΔPFS = 4.24 months), indicating significantly prolonged progression-free survival with ivonescimab combination th...
United Imaging Marks Five Years Since the Opening of its Global Showroom In North America with a Record Number of U.S. Customer Visits
The company launched American R&D in 2013 and American commercial operations in 2018; in 2020 it opened a 100,000 square foot production and training center in Houston, and just tripled its local footprint to support strong growth. HOUSTON, Oct. 19, 2025 /PRNewswire/ -- United Imaging, a global m...
From Test Drive to Co-Creation -- The 2025 Chery International User Summit Builds a New Mobility Ecosystem
WUHU, China, Oct. 19, 2025 /PRNewswire/ -- From October 17 to 21, under the theme"Co-Create • Co-Define," the 2025 Chery International User Summit gathered 1,200 guests from over 100 countries and regions in Wuhu. The event offered an immersive look at Chery's full-spectrum ecosystem — powered by...
From Product Export to Ecosystem Building -- Chery Reshapes the Global Automotive Landscape Through Co-Creation
WUHU, China, Oct. 19, 2025 /PRNewswire/ -- As the global automotive industry undergoes a once-in-a-century transformation, a profound paradigm shift is underway. While many automakers focus on tech paths and market rivalry, Chery has embraced an open approach—moving from "technology-driven" to "e...
International Technology Night: OMODA&JAECOO Leverage Power and Smart Mobility to Lead a New Wave of User Co-Creation
KUALA LUMPUR, Malaysia and WUHU, China, Oct. 19, 2025 /PRNewswire/ -- In October 2025, the OMODA&JAECOO International User Summit was grandly held to worldwide attention, with the International Technology Night becoming the highlight of the event. During this segment, OMODA&JAECOO's parent compan...
Breakthroughs in Energy and Power, Advancements in Intelligent Technology -- The 2025 Chery International Technology Night
WUHU, China, Oct. 19, 2025 /PRNewswire/ -- As the global new energy vehicle (NEV) industry accelerates toward electrification, hybrid technology has emerged as a crucial pathway, offering practical value and bridging the transition to full electrification. With its deep technical expertise and g...
SingPost Launches Residential Posting Box Trial to Bring Postal Services Closer to Home
Drives Partnerships to Enhance Network for Greater Agility and Customer Convenience SingPost's service touchpoints expands to 2500 SINGAPORE, Oct. 19, 2025 /PRNewswire/ -- Singapore Post Limited (SingPost) is strategically positioning its national delivery infrastructure to enhance community con...
The 2025 Chery International User Summit Opens a New Chapter as AiMOGA Robotics Unveils Its Global Brand Strategy
In today's rapidly evolving global industrial landscape, technological innovation has taken on a new mission. Its value now extends beyond individual product breakthroughs — toward building systemic ecosystems that integrate technology with users, scenarios, and society at large. WUHU, China, O...
Multitude Therapeutics Announces Encouraging Interim Phase I/II Results from Ongoing First-in-Human Study Evaluating its MUC18-directed Antibody-Drug-Conjugate, AMT-253, in Melanoma and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting
AMT-253 is a potential first-in-class MUC18-directed ADC with a proprietary linker-payload design AMT-253 demonstrated a manageable safety profile, consistent with other TOP1-inhibitor based ADCs Promising antitumor activity was observed in heavily pretreated patients with melanoma and gyneco...
Wialon Announces Top 10 GPS Hardware Manufacturers for 2025
DUBAI, UAE, Oct. 19, 2025 /PRNewswire/ -- Teltonika Telematics has once again
been recognized as the global leader in hardware for fleet management and
digitalization, taking the#1 position in the Wialon GPS Hardware Manufacturers
Top 10: 2025 edition
Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia
SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Primary plasma cell leukemia (pPCL) is a rare and highly aggressive plasma cell malignancy, often associated with complex genetic abnormalities. There is currently no standard treatment regimens, and conventional therapies for multiple myeloma are typically...
From Wellbeing to Academics: Why HK Parents Are Hitting Pause on Kids' Social Media and Device Use
Look Up Hong Kong-Ipsos survey of 651 parents backs a four-part plan for kids' wellbeing: delayed access to smartphones and social media, phone-free schools and more real-world activity and experiences. HONG KONG, Oct. 19, 2025 /PRNewswire/ -- Look Up Hong Kong, a new parent-led group launched ...
Week's Top Stories
Most Reposted
BoomerangFX Launches ChatGPT AI Search Advertising for Aesthetic, Wellness and Private-Pay Healthcare Practices, Powered by AUVIA™ AI Clinic Co-Pilot
[Picked up by 1315 media titles]
2026-11-17 23:03Manulife announces Subordinated Debenture issue
[Picked up by 1205 media titles]
2026-11-17 06:45vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
[Picked up by 1188 media titles]
2026-11-13 22:11The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1176 media titles]
2026-11-14 13:23Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence
[Picked up by 1172 media titles]
2026-11-12 23:00